Collaboration between Starkey and MED-EL on DualSync Technology: Pushing Boundaries in Bluetooth Connection for Cochlear Implant Users
In a groundbreaking collaboration, global hearing technology leaders Starkey and MED-EL have announced the introduction of DualSync, a bimodal streaming partnership designed to expand access to the latest hearing technology worldwide. The shared goal between Starkey and MED-EL is to make it easier for people everywhere to hear, communicate, and engage with the world using the most advanced technology available.
DualSync technology provides seamless audio connectivity and synchronized sound from compatible smartphones and media devices, transforming the experience for bimodal users – those who use a hearing aid in one ear and a cochlear implant in the other.
Starting July 1, 2025, Starkey Edge AI and Genesis AI hearing aids, and MED-EL Sonnet 3, Sonnet 2, Sonnet, and Rondo 3 audio processors will be compatible for bimodal streaming. This means that Apple technology will stream to compatible Starkey hearing aids and MED-EL cochlear implants, offering a unified listening experience.
The partnership between Starkey and MED-EL prioritizes global access to cutting-edge hearing technology and emphasizes personalized care in the delivery of hearing solutions. Brandon Sawalich, President and CEO of Starkey, stated that the collaboration reflects a shared commitment to delivering excellence without exception. Dr. Ingeborg Hochmair, co-founder and CEO of MED-EL, added that the partnership delivers a global solution for bimodal users, providing effortless connectivity, clearer sound, and greater control in daily lives.
DualSync empowers users with more natural, connected hearing, and the joint initiative focuses on patient-centric advancements in hearing technology. The partnership combines Starkey's industry-leading hearing aids with MED-EL's cochlear implant innovation for a seamless wireless audio experience.
With DualSync, Apple devices will recognize the hearing aid and cochlear implant as a single audio pair, eliminating the need for separate connections or accessories. Users will experience synchronized sound delivery to both ears, which can enhance speech understanding, music appreciation, and sound localization – key challenges for bimodal listeners.
The setup process is simplified, with Apple devices handling the pairing automatically once both devices are compatible. The partnership is designed to support ongoing innovation, with plans to include future device models from both companies.
Advances like DualSync contribute to greater digital inclusion for people with hearing loss, aligning with broader goals of accessibility in technology. This collaboration underscores the commitment of Starkey and MED-EL to delivering innovative hearing solutions tailored to individual needs.
- The digital health sector witnesses an exciting development as global leaders Starkey and MED-EL unveil DualSync, a groundbreaking technology that offers bimodal streaming for improved hearing.
- femtech news abuzz with the launch of DualSync, a bimodal streaming partnership, where Starkey and MED-EL are collaborating to deliver access to advanced hearing technology worldwide.
- In the realm of science and medical-conditions, the joint effort between Starkey and MED-EL targets the hearing-impaired, aiming to revolutionize health-and-wellness through smartphone and gadget integrations.
- With a focus on education-and-self-development and personal-growth, DualSync equips users with smarter hearing solutions, transforming their health-and-wellness journey using state-of-the-art technology.
- Moving forward, the harmony of Starkey's hearing aids and MED-EL's cochlear implants could pave the way for other tech collaborations in the field of technology, further enhancing the digital health landscape for various medical-conditions.
